| Jun 14 |
Retail investors are Galapagos NV's (AMS:GLPG) biggest owners and were hit after market cap dropped €74m
|
| May 30 |
Adaptimmune, Galapagos to collaborate on uza-cel T-cell therapy
|
| May 30 |
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future Solid Tumor Indications
|
| May 30 |
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future solid tumor indications
|
